🕒 Last update: loading…01/11/2026

Stock Danaher Corporation DHR

Danaher Corporation — Investlytic score 3/5 on the five criteria.

-
-
60/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 3/5 criteria met. Data as of 01/11/2026.

  • ✅ Price trend passed
  • ✅ Growth passed
  • ✅ Debt passed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2018 → 2019: 48.82%

Price change 2019 → 2020: 44.74%

Price change 2020 → 2021: 48.10%

Price change 2021 → 2022: -19.33%

Price change 2022 → 2023: -1.67%

Price change 2023 → 2024: -0.77%

Price change 2024 → 2025: -0.27%

Price change 2025 → 2026: 0.29%

Price change 2026 (year to date): -0.36%

Financial growth

Revenue CAGR (8 years): 5.36%

Earnings CAGR (8 years): 4.53%

Growth status: positive trend (>1%/yr) in revenue and earnings.

Debt

Debt-to-equity ratio: 0.35

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 28.75

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 3.12% from the high over 6 months.

Insufficient correction (< 10.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, mechanical verdict of the method (hold, watch, sell: the same for all) and the detail of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Danaher Corporation29.20.35+4.2 %🔒
Pfizer Inc.9.50.78−0.5 %–
Bristol-Myers Squibb Company10.72.55+6.2 %–
Sanofi10.30.28+2.5 %–
CVS Health Corporation11.41.06+10.0 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Danaher Corporation over the latest fiscal years.

Revenue
24.6 bn USD
fiscal year 2025
Net income
3.6 bn USD
fiscal year 2025
Net margin
14.7 %
fiscal year 2025
Average annual growth
+2.0 %
Revenue growth over 5 years
Average annual growth
+5.5 %
Revenue growth over 10 years
Market cap
164 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
202022.3 bn3.6 bn16.4 %n/a
202129.5 bn6.4 bn21.8 %+32.2 %
202226.6 bn7.2 bn27.1 %-9.5 %
202323.9 bn4.8 bn19.9 %-10.3 %
202423.9 bn3.9 bn16.3 %-0.1 %
202524.6 bn3.6 bn14.7 %+2.9 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Danaher Corporation over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
solid accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
3.77
safe zone (above 2.99)
Piotroski Score
7 / 9
7 to 9: solid accounts
DCF Value
191.50 USD
DCF close to share price · share price 234.43 USD, gap -18.3 %
Net Debt / EBITDA
2.93 x
moderate debt
Fiscal year20212022202320242025
Cash and investments2.6 bn6.0 bn5.9 bn2.1 bn4.6 bn
Total Debt23.3 bn20.6 bn19.5 bn17.1 bn18.4 bn
Net Debt20.7 bn14.6 bn13.7 bn15.1 bn13.8 bn
Equity45.2 bn50.1 bn53.5 bn49.5 bn52.5 bn
Total assets83.2 bn84.3 bn84.5 bn77.5 bn83.5 bn
Operating cash flow8.4 bn8.5 bn7.2 bn6.7 bn6.4 bn
Investments (capex)1.3 bn1.2 bn1.4 bn1.4 bn1.2 bn
Free cash-flow7.1 bn7.4 bn5.8 bn5.3 bn5.3 bn
Share buybacks0006.0 bn3.1 bn
Dividends paid742 m818 m821 m768 m878 m

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)37.94 x
Price / book value3.05 x
Return on Equity (ROE)8.2 %
Return on Invested Capital (ROIC)5.4 %
Net margin16.9 %
Debt / equity0.49 x
Current ratio1.63 x
Interest coverage35.74 x
Free cash-flow yield3.5 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 18/11/2026.

+

Valuation and competitors

Danaher Corporation compared with its sector on the same exchange and with its main competitors.

Company P/E
29.2
close to the sector
Sector median P/E
27.7
healthcare, NYSE
Sector over 10 years
22.3
10-year median, range 18.4 to 44.9

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Danaher Corporation164 bn29.214.7 %
Thermo Fisher Scientific Inc. TMO259 bn30.215.1 %
Waters Corporation WAT45.2 bn33.620.3 %
Agilent Technologies, Inc. A49.1 bn29.918.8 %
Revvity, Inc. RVTY17.2 bn28.98.5 %
Bruker Corporation BRKR9.4 bn30.9-0.2 %
Qiagen N.V. QGEN10.3 bn20.620.3 %
Illumina, Inc. ILMN31.3 bn41.219.6 %
Mettler-Toledo International Inc. MTD34.6 bn40.021.6 %
Sector median (NYSE)27.7

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Danaher Corporation publish: ratings, price targets and earnings forecasts.

Majority rating
buy
43 analysts
Average price target
244.63 USD
from 195.00 USD to 275.00 USD, 32 targets over 12 months
Gap with the share price
+6.2 %
price 230.25 USD on 06/11/2026

Breakdown of ratings

strong buy 1buy 30hold 11sell 1strong sell 0

Analysts' average target 244.63 USD, DCF value 191.50 USD, share price 230.25 USD.

Average target over the last 3 months: 259.00 USD (11 targets).

Analyst forecasts

Fiscal yearRevenueNet incomeExpected EPS (range)P/E on this EPSAnalysts
202626.3 bn6.1 bn8.59 (8.55 / 8.61)26.813
202728.3 bn6.6 bn9.31 (9.26 / 9.40)24.714
202830.1 bn7.2 bn10.24 (8.60 / 11.76)22.57

Amounts in USD, the reporting currency.

Track record against expectations: reported EPS above consensus 11 times over the last 12 releases.

Rating changes (12 months)

DateFirmBeforeAfter
22/10/2026CitigroupBuyBuy
22/10/2026JP MorganOverweightOverweight
22/10/2026TD CowenBuyBuy
22/10/2026BarclaysOverweightOverweight
22/10/2026StifelBuyBuy

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.

+

Dividends and earnings

Danaher Corporation: dividend history, last distributions, stock splits and earnings releases.

Frequency
quarterly
Last dividend
0.400 USD
ex-dividend on 30/09/2026
Last 12 months
1.52 USD
number of payments: 4
Yield
0.5 %
on the last known price
Years of increases
13
consecutive
Years of payments
33
uninterrupted
06.2512.5018.7525.002007 : 0.0370 USD2008 : 0.0403 USD20082009 : 0.0437 USD2010 : 0.0538 USD20102011 : 0.0605 USD2012 : 0.0672 USD20122013 : 0.0672 USD2014 : 0.269 USD20142015 : 0.498 USD2016 : 25.00 USD20162017 : 0.496 USD2018 : 0.567 USD20182019 : 0.603 USD2020 : 0.638 USD20202021 : 0.745 USD2022 : 0.887 USD20222023 : 0.989 USD2024 : 1.08 USD20242025 : 1.28 USD2026 : 1.20 USD2026

Annual dividend per share (USD), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.

Latest ex-dividend dates

Ex-dividendAmountPayment
30/09/20260.400 USD30/10/2026
26/06/20260.400 USD31/07/2026
27/03/20260.400 USD24/04/2026
26/12/20250.320 USD30/01/2026
26/09/20250.320 USD31/10/2025
27/06/20250.320 USD25/07/2025
28/03/20250.320 USD25/04/2025
27/12/20240.270 USD31/01/2025

Earnings releases

DatePublished EPSExpected EPSSurprise
21/10/20262.111.92+9.9 %
21/07/20261.941.85+4.9 %
21/04/20262.061.94+6.2 %
28/01/20262.232.16+3.2 %
21/10/20251.891.72+9.9 %
22/07/20251.801.64+9.8 %

Stock splits

DateOperation
02/10/2023split: 141 shares for 125
05/07/2016split: 1,319 shares for 1,000
14/06/2010split: 2 shares for 1
21/05/2004split: 2 shares for 1
01/06/1998split: 2 shares for 1
23/01/1995split: 2 shares for 1

Factual data: ex-dividend history and earnings calendar, as of 18/11/2026. A past dividend does not guarantee the next one.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Danaher Corporation.

Free float
89.0 %
share of freely traded shares
Institutions
82.7 %
2,196 declared holders, 2026Q2
Large funds tracked
38
hold the stock as of 2026Q2
Executives (insiders)
0 / 9
0 purchases, 9 sales in 130 days
US elected officials
16
11 purchases, 5 sales in 12 months

Indices: S&P 500 (since 18/11/1998).

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Vanguard Group61.0 m14.0 bn0.2 %+0.1 %2025Q4
State Street56.9 m10.9 bn0.2 %+104.0 %2026Q2
BlackRock55.1 m10.5 bn0.2 %+6.7 %2026Q2
Fidelity29.5 m5.6 bn0.2 %+31.1 %2026Q2
Wellington Management16.3 m3.1 bn0.5 %+10.4 %2026Q2
Geode Capital Management14.3 m2.7 bn0.1 %+1.0 %2026Q2
JPMorgan Chase12.2 m2.3 bn0.1 %-28.0 %2026Q2
T. Rowe Price11.5 m2.2 bn0.2 %-25.4 %2026Q2

Latest insider transactions

DatePersonSideAmount
09/11/2026Mcgrew Matthewsale4.1 m USD
09/11/2026Milosevich Gregory Msale484,302 USD
28/10/2026Bouda Christophersale1.0 m USD
28/10/2026Bouda Christophersale763,094 USD
28/10/2026Mcgrew Matthewsale3.3 m USD
28/10/2026Mcgrew Matthewsale3.7 m USD

Elected officials' disclosures

DateOfficialSideAmount
13/10/2026Ro Khannapurchase$1,001 - $15,000
02/09/2026Kevin Hernsale$1,001 - $15,000
31/08/2026Kevin Hernsale$15,001 - $50,000
27/03/2026Alan Armstrongpurchase$1,001 - $15,000
16/06/2026Michael T. McCaulpurchase$1,001 - $15,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 18/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 29/12/1978
ISIN code
US2358511028
Workforce
61,000
full-time employees
Chief executive
Rainer M. Blair
Next earnings
27/01/2027

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Danaher Corporation

What is the Danaher Corporation share price?

Latest recorded price: 233.02 USD on 13/11/2026, for a market cap of 164 bn USD.

What is the revenue of Danaher Corporation?

24.6 bn USD for fiscal year 2025, with net income of 3.6 bn USD (net margin 14.7 %).

Does Danaher Corporation pay a dividend?

Yes. Latest dividend: 0.400 USD per share, ex-dividend on 30/09/2026. Over 12 months: 1.52 USD. Yield on the latest known price: 0.5 %.

When does Danaher Corporation report its next earnings?

The next release is expected on 27/01/2027. EPS expected by analysts: 2.49.

What do analysts say about Danaher Corporation?

Out of 43 analysts: 31 buy or strong buy, 11 hold, 1 sell or strong sell. Average price target: 244.63 USD, i.e. +6.2 % from the share price.

What is the P/E ratio of Danaher Corporation?

Trailing 12-month P/E of 29.2, against 27.7 for the sector median on the same exchange (10-year median: 22.3).

Is Danaher Corporation stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US2358511028).

How many employees does Danaher Corporation have?

61,000 full-time employees according to the latest published profile.

Who runs Danaher Corporation?

Rainer M. Blair is the company's chief executive.

Which large funds own Danaher Corporation?

As of 2026Q2, among the large funds tracked: Vanguard Group, State Street, BlackRock, Fidelity, Wellington Management.

07

Similar stocks